LYCOS RETRIEVER 
Remicade: Infliximab
built 655 days ago
The European Commission (EC) has approved a shortened infusion time for Remicade® (infliximab) in patients with rheumatoid arthritis (RA). The shortened infusion time will allow carefully selected patients with RA who have tolerated three initial two-hour infusions of Remicade to be administered subsequent infusions over one hour, halving the infusion time. Shortened infusions at doses greater than 6mg/kg have not been studied.
Source:
Infliximab is available with a prescription under the brand name Remicade. Other brand or generic formulations may ... be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.
Source:
MORE ABOUT
Infliximab